Polypoidal Choroidal Vasculopathy Revealed by Progressive Visual Loss in a 75- Year-Old Hypertensive Patient: A Case Report

Research Area: Medicine Authors
Cheikhna BEGNOUG* Othman KARMANE Mohamed El Moustava BEICHE Mohamed SALEM SALEM Mariem KANKOU Fatima EL IBRAHIMI Younes AKANNOUR El hassan ABDELLAH
University Mohammed V RABAT MOROCCO

Abstract
Background:
Polypoidal choroidal vasculopathy (PCV) is a subtype of macular neovascular disease characterized by aneurysmal polypoidal dilations arising from abnormal choroidal vascular networks. It is often associated with age-related macular degeneration and may lead to progressive visual impairment. Case presentation:
We report the case of a 75-year-old female patient with a history of systemic hypertension for 10 years who presented with progressive visual acuity decline evolving for approximately one year. Fundus examination revealed an abnormal macular reflex. Optical coherence tomography (OCT) showed a large pigment epithelial detachment associated with macular thickening. Fluorescein angiography demonstrated progressive hyperfluorescence with late leakage consistent with choroidal neovascularization. Conclusion:
This case highlights the importance of multimodal retinal imaging in diagnosing polypoidal choroidal vasculopathy and identifying associated neovascular activity.

Keywords
Polypoidal choroidal vasculopathy; OCT; fluorescein angiography; choroidal neovascularization; macular disease;

Doi : https://doi.org/10.5281/zenodo.19114053

PDF File


Cite
BEGNOUG, C., KARMANE, O., BEICHE, M. E. M., SALEM SALEM, M., KANKOU, M., EL IBRAHIMI, F., AKANNOUR, Y., & ABDALLAH, E. H. (2026). Polypoidal Choroidal Vasculopathy Revealed by Progressive Visual Loss in a 75-Year-Old Hypertensive Patient: A Case Report. International Journal of Science, Applications and Prosperity, 4(1), 6‑12. https://doi.org/10.5281/zenodo.19114053

Licence
Creative Commons Attribution Share Alike 4.0 International

References
[1] S Yannuzzi, L. A., Sorenson, J., Spaide, R. F., & Lipson, B. (2012). Idiopathic polypoidal choroidal vasculopathy (IPCV). Retina, 32, 1-8.
[2] Ciardella, A. P., Donsoff, I. M., Huang, S. J., Costa, D. L., & Yannuzzi, L. A. (2004). Polypoidal choroidal vasculopathy. Survey of ophthalmology, 49(1), 25-37.
[3] Wong, T., Chakravarthy, U., Klein, R., Mitchell, P., Zlateva, G., Buggage, R., ... & Sledge, I. (2008). The natural history and prognosis of neovascular age-related macular degeneration: a systematic review of the literature and meta-analysis. Ophthalmology, 115(1), 116-126.
[4] Koh, Adrian, et al. "EVEREST study: efficacy and safety of verteporfin photodynamic therapy in combination with ranibizumab or alone versus ranibizumab monotherapy in patients with symptomatic macular polypoidal choroidal vasculopathy." Retina 32.8 (2012): 1453-1464.
[5] Cheung, Chui Ming Gemmy, et al. "Polypoidal choroidal vasculopathy: definition, pathogenesis, diagnosis, and management." Ophthalmology 125.5 (2018): 708-724.
[6] Spaide RF, Yannuzzi LA, Slakter JS, et al. Indocyanine green videoangiography of idiopathic polypoidal choroidal vasculopathy. Retina. 1995;15(2):100–110.
[7] Laude, Augustinus, et al. "Polypoidal choroidal vasculopathy and neovascular age-related macular degeneration: same or different disease?." Progress in retinal and eye research 29.1 (2010): 19-29.
[8] Lim, T. H., A. Laude, and C. S. H. Tan. "Polypoidal choroidal vasculopathy: an angiographic discussion." Eye 24.3 (2010): 483-490.
[9] Gomi, F., & Tano, Y. (2008). Polypoidal choroidal vasculopathy and treatments. Current opinion in ophthalmology, 19(3), 208-212.
[10] Baek, J., Lee, J. H., Jeon, S., & Lee, W. K. (2019). Choroidal morphology and short-term outcomes of combination photodynamic therapy in polypoidal choroidal vasculopathy. Eye, 33(3), 419-427.